Table 4.
Recipient Characteristics | MDs Alive (n = 44) | MDs Mortality (n = 19) | p | Multivariate Analysis |
---|---|---|---|---|
n (%) or Median (IQR) | n (%) or Median (IQR) | |||
Listing status | 0.12 | |||
2B | 24 (55%) | 3 (16%) | ||
2A | 12 (27%) | 9 (47%) | ||
1 | 3 (7%) | 4 (21%) | ||
HU | 5 (11%) | 3 (16%) | ||
Peripheral vascular disease | 2 (5%) | 4 (21%) | 0.01 | |
Platelets count (103/mm3) | 187 (167–249) | 189 (128–255) | 0.13 | |
Bilirubin (µmol/L) | 13 (7–21) | 20 (10–44) | 0.08 | |
C-reactive Protein (mg/L) | 3.8 (2.9–15.1) | 26 (4–99) | 0.12 | |
eGFR (mL/min/m2) | 60 (49–84) | 47 (42–53) | 0.02 | HR 0.98 (0.95–0.99; p = 0.04) |
Inotropic support | 5 (11%) | 10 (53%) | <0.01 | HR 3.96 (1.17–13.44; p = 0.03) |
CVVH | 0 (0%) | 3 (16%) | <0.01 | |
Mechanical ventilation | 1 (2%) | 3 (16%) | 0.08 | |
ICU stay | 8 (18%) | 7 (37%) | 0.13 | |
Paracorporeal-LVAD | 1 (2%) | 2 (11%) | 0.17 | |
Donors Characteristics | MDs Alive (n = 44) | MDs Mortality (n = 19) | p | Multivariate Analysis |
n (%) or Median (IQR) | n (%) or Median (IQR) | |||
Cold ischemic time (min) | 200 (149–234) | 216 (169–240) | 0.12 | |
Hypertension | 6 (14%) | 6 (32%) | 0.13 | |
Donor/Recipient BSA | 0.0 (−0.2–0.1) | 0.1 (0.0–0.2) | 0.12 |
Abbreviations: CVVH, continuous venovenous hemofiltration; GFR, glomerular filtration rate; HU, high urgency; BSA, body surface area; ICU, intensive care unit; LVAD, left ventricular assistance device.